arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Penumbra Inc

PEN
$324.57 ▼ -0.26 (-0.08%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
14 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

Penumbra Inc shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $12.6B
Dividend Yield
Revenue Growth 17.5%
Op. Margin 13.5%
ROIC 11.5%
FCF / Share $4.49
Trailing P/E 71.0x
Price / Book 8.9x
FCF Yield 1.4%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.40B
↑ +17.5%
Net Income Profit after all expenses
$177.69M
↑ +1168.1%
Operating Margin Operating profit as % of sales
13.5%
↑ +1635.8% 64th
FCF / Share Free cash flow per share
$4.49
↑ +17.9%

Health Breakdown

Profitability
67
Returns
75
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters